Safety and Efficacy of Mexidol® for ADHD in Children Aged 6-12
NCT06854601
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
333
Enrollment
INDUSTRY
Sponsor class
Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Anxiety Disorders and Symptoms
Interventions
DRUG:
Mexidol
DRUG:
Placebo
DRUG:
Mexidol + Placebo
Sponsor
Pharmasoft